Theodore J. Lowenkopf, M.D.
Medical Director, Providence Stroke Center
Dr. Lowenkopf is a leader in the field of stroke neurology. Since finishing his medical education at Jefferson Medical College in 1993, he was chief resident in neurology at Albert Einstein College of Medicine in Bronx, New York, and completed a fellowship in cerebrovascular disease at the Washington University School of Medicine in St. Louis, Missouri. While in St. Louis, Dr. Lowenkopf redesigned the acute stroke team response to include 24-hour coverage, with a less than 15-minute in-house consultation response time for Emergency Department/Ward Consultation. He supervised the creation of emergent stroke treatment pathways and EMS standard protocols for stroke. Dr. Lowenkopf completed his internal medicine residency at Providence Portland Medical Center.
Since coming to Providence St. Vincent Medical Center, Dr. Lowenkopf has created a multidisciplinary approach to stroke management and has coordinated the development of care pathways designed to enhance the treatment of the stroke patient.
As a member of the Oregon Stroke Center response team, Dr. Lowenkopf has been the primary or associate investigator for clinical research trials pioneering new methods in the treatment of stroke.
Todd Kuether, M.D.
Neurointerventionalist
As medical director of Providence Neurointerventional Services, Dr. Kuether
has helped build a program that has greatly expanded the treatment options
for people with a variety of conditions affecting the brain and spinal cord.
Under Dr. Kuether’s direction, the program’s highly trained specialists use
catheters to perform intricate procedures without the trauma of surgery. In
these procedures, a catheter is guided through a patient’s blood vessel to
the exact site of a problem in the brain or spine. Then microscopic tools
are threaded through the catheter to the site, where they are used to repair
aneurysms, remove blood clots, open blocked vessels, alleviate debilitating
arteriovenous malformations, cut off the blood supply to vascular tumors, and
perform many other life-saving treatments.
In addition to leading Providence Neurointerventional Services, Dr. Kuether is
an integral part of Providence Stroke Center, Oregon’s first nationally certified
program for stroke care.
Dr. Kuether earned his medical degree at the University of Kansas School of
Medicine, where he earned numerous awards and scholarships. He completed a
surgical internship, a neurological surgery residency and a neurointerventional
fellowship at Oregon Health and Science University. He has practiced with
Microneurosurgical Consultants in Portland since 2000.
Lisa Yanase, M.D.
Associate Medical Director, Providence Stroke Center, Providence Brain Institute
In her role as associate medical director of Providence Stroke Center at Providence Portland Medical Center, Dr. Lisa Yanase focuses on three major areas of responsibility. They are: developing patient care protocols to minimize the risk of stroke and to optimize the outcomes of stroke care; developing professional, patient and public education about stroke prevention, detection and treatment; and coordinating with the Oregon Stroke Center to expand the number of new drugs and technologies available to patients through clinical trials.
Before joining Providence in August 2005, Dr. Yanase spent four years as the medical director of the Cerebrovascular Center at LDS Hospital in Salt Lake City, Utah. In that role, she built from the ground up a stroke center certified by the Joint Commission on Accreditation of Healthcare Organizations. Prior to that, she held a faculty position in pediatric neurology with Primary Children’s Medical Center in Salt Lake City.
Dr. Yanase obtained her medical degree from the University of North Carolina School of Medicine in Chapel Hill. She completed a neurology residency at the University of Utah, and a fellowship in stroke/ICU neurology at Washington University in St. Louis, Mo. She has participated as a subinvestigator in numerous clinical trials focusing on stroke prevention and on early-stage treatments to minimize long-term disability.
